Literature DB >> 22883375

Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews.

Tae-Hun Kim1, Hyun-Ja Lim, Myung-Sunny Kim, Myeong Soo Lee.   

Abstract

Benign prostatic hyperplasia (BPH) is a common chronic condition in older men. The aim of this overview of systematic reviews (SRs) is to summarise the current evidence on the efficacy and adverse effects of dietary supplements for treating BPH with lower urinary tract symptoms. We searched 5 electronic databases and relevant overviews without limitations on language or publication status. Six SRs of 195 articles were included in this overview. Serenoa repens was reviewed in 3 studies and no specific effect on BPH symptoms and urinary flow measures was observed. However, β-sitosterol, Pygeum africannum and Cernilton were reviewed in one study each, and significant improvement was observed for all three. All the included compounds have mild and infrequent adverse effects. SRs on β-sitosterol, Pygeum africannum and Cernilton have not been updated since 2000, thus an update of reviews on these compounds will be necessary in the future.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22883375     DOI: 10.1016/j.maturitas.2012.07.007

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  11 in total

1.  Role of complimentary therapy for male LUTS.

Authors:  Philippa J Cheetham
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  Valorization of coffee leaves as a potential agri-food resource: bio-active compounds, applications and future prospective.

Authors:  Siddhi Patil; M Vedashree; Pushpa S Murthy
Journal:  Planta       Date:  2022-02-14       Impact factor: 4.116

Review 3.  Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.

Authors:  Kalyan J Gangavarapu; Peter F Jowdy; Barbara A Foster; Wendy J Huss
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

Review 4.  Adverse drug reactions in some African herbal medicine: literature review and stakeholders' interview.

Authors:  Bernard Kamsu-Foguem; Clovis Foguem
Journal:  Integr Med Res       Date:  2014-05-23

5.  Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia.

Authors:  Bo-Ram Jin; Hyo-Jung Kim; Sang-Kyun Park; Myoung-Seok Kim; Kwang-Ho Lee; Il-Joo Yoon; Hyo-Jin An
Journal:  Molecules       Date:  2018-10-14       Impact factor: 4.411

6.  Effect of Paecilomyces tenuipes Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Sprague-Dawley Rats.

Authors:  Young-Jin Choi; Eun-Kyung Kim; Meiqi Fan; Yujiao Tang; Young Joung Hwang; Si-Heung Sung
Journal:  Int J Environ Res Public Health       Date:  2019-10-07       Impact factor: 3.390

7.  Astaxantin and Isoflavones Inhibit Benign Prostatic Hyperplasia in Rats by Reducing Oxidative Stress and Normalizing Ca/Mg Balance.

Authors:  Alexander L Semenov; Ekaterina A Gubareva; Elena D Ermakova; Anastasia A Dorofeeva; Irina A Tumanyan; Ekaterina A Radetskaya; Maria N Yurova; Saied A Aboushanab; Osman N Kanwugu; Elena I Fedoros; Andrey V Panchenko
Journal:  Plants (Basel)       Date:  2021-12-12

Review 8.  Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Authors:  Letteria Minutoli; Mariagrazia Rinaldi; Herbert Marini; Natasha Irrera; Giovanni Crea; Cesare Lorenzini; Domenico Puzzolo; Andrea Valenti; Antonina Pisani; Elena B Adamo; Domenica Altavilla; Francesco Squadrito; Antonio Micali
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

9.  6'-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb-AR Pathway.

Authors:  Bo-Ram Jin; Hyo-Jung Kim; Eun-Yeong Kim; Tae-Wook Chung; Ki-Tae Ha; Hyo-Jin An
Journal:  Nutrients       Date:  2019-09-12       Impact factor: 5.717

10.  Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.

Authors:  Bo-Ram Jin; Hyo-Jin An
Journal:  Aging (Albany NY)       Date:  2020-02-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.